Volume 51, Issue 1, Pages (January 2007)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 70, Issue 1, Pages (July 2016)

Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management Michael O’Leary European Urology Supplements

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Steven A. Kaplan,

Volume 51, Issue 1, Pages (January 2007)

Volume 50, Issue 5, Pages (November 2006)

Volume 69, Issue 1, Pages (January 2016)

Volume 53, Issue 5, Pages (May 2008)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Volume 45, Issue 4, Pages (April 2004)

Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer Olav Erich Yri, Trine Bjoro, Sophie D.

John P. Mulhall, Francesco Montorsi European Urology

Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,

Volume 52, Issue 1, Pages (July 2007)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Raymond C. Rosen, Francois Giuliano, Culley.

Volume 52, Issue 3, Pages (September 2007)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 70, Issue 3, Pages (September 2016)

Prostate Cancer Detection: A View of the Future

Volume 56, Issue 2, Pages (August 2009)

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 68, Issue 1, Pages (July 2015)

Volume 64, Issue 4, Pages (October 2013)

Volume 70, Issue 1, Pages (July 2016)

Volume 61, Issue 3, Pages (March 2012)

Counselling the Prostate Cancer Patient

Volume 49, Issue 6, Pages (June 2006)

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old P. Perrin,

Trends in Hypospadias Surgery: Results of a Worldwide Survey

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.

Richard C. Harkaway European Urology Supplements

The Economic Costs of Overactive Bladder in Germany

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 53, Issue 1, Pages (January 2008)

Volume 50, Issue 3, Pages (September 2006)

Volume 50, Issue 5, Pages (November 2006)

2005 Update on Pathology of Prostate Biopsies with Cancer

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 51, Issue 1, Pages (January 2007)

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

Volume 74, Issue 5, Pages (November 2018)

Testicular Cancer Variations in Time and Space in Europe

Volume 53, Issue 1, Pages (January 2008)

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

Profile of Silodosin European Urology Supplements

Economic Burden of Bladder Cancer Across the European Union

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Bertrand Tombal, Richard Berges

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

2005 Update on Pathology of Prostate Biopsies with Cancer

Presentation transcript:

Volume 51, Issue 1, Pages 207-216 (January 2007) The Efficacy of Drugs for the Treatment of LUTS/BPH, A Study in 6 European Countries Annie Hutchison, Richard Farmer, Katia Verhamme, Richard Berges, Remigio Vela Navarrete European Urology Volume 51, Issue 1, Pages 207-216 (January 2007) DOI: 10.1016/j.eururo.2006.06.012 Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 1 Mean change in IPSS (with 99% CI) for patients prescribed only the named drug during the study period. European Urology 2007 51, 207-216DOI: (10.1016/j.eururo.2006.06.012) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 2 Reduction in IPSS over study period for patients receiving only a single class of drug. European Urology 2007 51, 207-216DOI: (10.1016/j.eururo.2006.06.012) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 3 Reduction in IPSS over study period for patients receiving only a named non-phytotherapy drug over the study period. European Urology 2007 51, 207-216DOI: (10.1016/j.eururo.2006.06.012) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 4 Reduction in IPSS over study period for patients receiving only a named phytotherapy drug over the study period. European Urology 2007 51, 207-216DOI: (10.1016/j.eururo.2006.06.012) Copyright © 2006 European Association of Urology Terms and Conditions